The dilemmas of prostate cancer screening

Ian E Haines
Med J Aust 2013; 199 (9): . || doi: 10.5694/mja13.10833
Published online: 4 November 2013

To the Editor: Recent articles in the Journal evaluating the evidence on screening for early-stage prostate cancer1,2 failed to mention one of the most important pieces of evidence ever published on the treatment of prostate cancer.3 This randomised controlled trial (RCT) showed that, compared with observation, radical prostatectomy did not significantly reduce all-cause or prostate cancer mortality over at least 12 years among men with clinically localised prostate cancer diagnosed in the era of prostate-specific antigen (PSA) testing.3

  • Ian E Haines

  • Monash University at Cabrini Health, Melbourne, VIC.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.